Investment firms The Carlyle Group Inc. (NASDAQ:CG) and SK Capital Partners, together with Beacon Parent Holdings, L.P., have ...

Willingham says that once it's set out, china at Bluebird tends to sell quickly — just not to millennials. Diane Cowen worked at the Houston Chronicle from 2000 to 2023, most recently as its ...

Lee Canyon is set to open its Bluebird chairlift on Thursday ... announces $5.5 billion charge to comply with new Trump rule ‘China’s Elon Musk’ uses just two numbers to demonstrate why ...

Willingham says that once it's set out, china at Blue Bird tends to sell quickly - just not to millennials.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--bluebird bio, Inc. (NASDAQ: BLUE) today announced that October 19, 2021 has been set as the record date for the dividend of shares of common stock of 2seventy to ...

(Reuters) - Bluebird bio Inc < BLUE.O> said on Monday it has set at $419,500 the wholesale list price of its newly approved multiple myeloma therapy developed with Bristol-Myers Squibb Co. The U.S ...

Bluebird reached speeds up 150mph (240kph) during trial runs in August The man behind the restoration of Bluebird plans to run the vessel on a Scottish loch for a second summer, despite the threat ...

PILLAGER — A bluebird nest box monitoring class is scheduled for 9:30 to 11 a.m. April 5, at the Pillager Community Center. Each spring, thousands of bluebirds return to Minnesota from Kansas ...

Bird & Bird sets up local trademark firm in China The agency will operate under the banner 'Bird & Bird IP (Beijing) Co Ltd' and is a wholly-owned subsidiary of the firm.

(Reuters) - Bluebird bio Inc on Friday set a price for its gene therapy, Zynteglo, at 1.58 million euros ($1.78 million) over five years, after winning conditional approval in Europe this month to ...

Bluebird Bio Inc.’s elivaldogene autotemcel (eli-cel) gained U.S. approval late Sept. 16 for use in early active cerebral adrenoleukodystrophy (CALD), making it the firm’s second gene therapy to clear ...